Back to Search Start Over

Early neurologically focused follow-up after cardiac arrest is cost-effective: A trial-based economic evaluation.

Authors :
Moulaert VR
Goossens M
Heijnders IL
Verbunt JA
Heugten CM
Source :
Resuscitation [Resuscitation] 2016 Sep; Vol. 106, pp. 30-6. Date of Electronic Publication: 2016 Jun 25.
Publication Year :
2016

Abstract

Objective: To evaluate the cost-effectiveness of an early intervention service for cardiac arrest survivors called 'Stand still …, and move on' from a societal perspective.<br />Intervention: This concise nursing intervention consists of screening for cognitive and emotional problems, information provision and support, self-management promotion, and further referral if necessary. Earlier research confirmed the feasibility of the intervention and its effectiveness in improving emotional functioning and quality of life.<br />Methods: In this multicentre randomized controlled trial with one year follow-up 185 patients were included between April 2007 and December 2010. The experimental group received the intervention, the control group received care-as-usual. Intervention costs, other direct healthcare costs (e.g. hospital care, rehabilitation, medication, home care) and indirect costs (productivity loss) were measured during ten months using monthly cost-diaries. The economic evaluation comprised a cost-utility analysis (SF-36) and a cost-effectiveness analysis (QOLIBRI) using bootstrapping (5000 replications) to quantify uncertainty concerning the incremental cost effectiveness ratio (ICER), and the probability of the intervention being cost-effective was estimated. To check the robustness of the findings, two sensitivity analyses were performed using the EQ-5D and the complete cases respectively.<br />Results: Of 136 (74%) participants sufficient data concerning costs were collected to be included in this economic evaluation. Intervention costs were on average €127 (SD 85). No significant differences between groups were found with regard to overall costs. The ICERs of the cost-utility and the cost-effectiveness analyses supported the cost-effectiveness of the intervention. The probability of the intervention being cost-effective was 54-76% for the SF-36 and 94% for the QOLIBRI. Findings were robust.<br />Conclusion: The intervention 'Stand still …, and move on' has positive societal economic effects and has a high probability to be cost-effective. Implementation in regular healthcare is recommended.<br />Trial Registration: ISRCTN74835019.<br /> (Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1873-1570
Volume :
106
Database :
MEDLINE
Journal :
Resuscitation
Publication Type :
Academic Journal
Accession number :
27350371
Full Text :
https://doi.org/10.1016/j.resuscitation.2016.06.015